The role of MCPIP1 protein in growth, progression and vascularisation of clear cell renal cell carcinoma.

2015/19/B/NZ5/01405

Keywords

Descriptors

  • NZ5_7: Leczenie chorób człowieka
  • NZ5_3: Patogeneza chorób człowieka

Panel

NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr hab. Katarzyna Miękus

Number of co-investigators in the project: 7

Call

OPUS 10 – announced on 2015-09-15

Amount awarded
788 400 PLN
Project start date
2016-06-23
Project end date
2021-06-22
Project duration
60 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Equipment purchased [PL]

  1. cytometr przepływowy. Cost: 160 000 PLN
  2. komputer. Cost: 5 000 PLN
  3. lodówka. Cost: 3 000 PLN

Information in the final report

Publication in academic press/journals (4)

  1. C-Met as a Key Factor Responsible for Sustaining Undifferentiated Phenotype and Therapy Resistance in Renal Carcinomas

    Authors:
    Paulina Marona , Judyta Górka, Jerzy Kotlinowski, Marcin Majka , Jolanta Jura, Katarzyna Miekus
    Academic press:
    Cells (year: 2019, volume: 272, pages: 8; MDPI używa nr artykułów, zamiast nr stron), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/cells8030272 – link to the publication
  2. MCPIP1 downregulation in clear cell renal cell carcinoma promotes vascularization and metastatic progression

    Authors:
    Marona P, Górka J., Mazurek Z, Wilk W, Rys J, Majka M, Jura J, Miekus K
    Academic press:
    Cancer Research (year: 2017, volume: Sep 15;77(18), pages: 4905-4920), Publisher: AACR
    Status:
    Published
    DOI:
    10.1158/0008-5472 – link to the publication
  3. The anti-inflammatory protein MCPIP1 inhibits the development of ccRCC by maintaining high levels of tumour suppressors

    Authors:
    Judyta Gorka, Paulina Marona, Oliwia Kwapisz, Janusz Rys, Jolanta Jura, Katarzyna Miekus
    Academic press:
    European Journal of Pharmacology (year: 2020, volume: 888, pages: 173591), Publisher: Elsevier
    Status:
    Published
  4. MCPIP1 inhibits Wnt/β-catenin signaling pathway activity and modulates epithelial-mesenchymal transition during clear cell renal cell carcinoma progression by targeting miRNAs

    Authors:
    Judyta Gorka, Paulina Marona, Oliwia Kwapisz, Agnieszka Waligórska, Ewelina Pospiech, Jurek W Dobrucki, Janusz Rys, Jolanta Jura, Katarzyna Miekus
    Academic press:
    Oncogene (year: 2021, volume: 50, pages: 6720-6735), Publisher: Nature Publishing Group
    Status:
    Published
    DOI:
    10.1038/s41388-021-02062-3 – link to the publication

Articles in post-conference publications (1)

  1. RNase activity of MCPIP1 regulates key elements of mesenchymal phenotype of clear cell renal cell carcinoma cells

    Authors:
    Miekus, K; Marona, P ; Gorka, J; Jura, J
    Conference:
    Annual Meeting of the American-Association-for-Cancer-Research (AACR) (year: 2018, pages: Volume: 78 Issue: 13, S Meeting Abstract: 5003), Publisher: Cancer Research
    Date:
    conference APR 14-18, 2018
    Status:
    Published
    DOI:
    link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski